New CGM tech could catch gestational diabetes earlier, protecting moms and babies
NCT ID NCT07276945
First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This study aims to improve how gestational diabetes is diagnosed by using continuous glucose monitoring (CGM) technology instead of the standard single blood test. Researchers will enroll 300 pregnant women early in pregnancy (within 14 weeks) and use CGM data along with AI tools to detect diabetes sooner. The goal is to start treatment earlier, which may reduce health risks for both mother and baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.